Statistics

Total Visits

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)54

Select a period of time:

Number of views in the range

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)38

Views

Views
March 202515
April 20252
May 20250
June 20250
July 202520
August 20251
September 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States7
Brazil5
Dominican Republic1
Ecuador1
Egypt1
Spain1
Ethiopia1
United Kingdom1
Kenya1
 

Top cities views

Views
Al Mansurah1
Araçatuba1
Awasa1
Blumenau1
Council Bluffs1
East London1
Elkhart1
Everett1
Juiz de Fora1
Madisonville1